Cited by 463SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

The DOI matches its Crossref record; 250 of the 275 references it cites were found in a registry or an index.

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

Open access

Ortiz-Prado, Esteban, Simbaña-Rivera, Katherine, Gómez- Barreno, Lenin, Rubio-Neira, Mario, Guaman, Linda P., Kyriakidis, Nikolaos C, Muslin, Claire, Jaramillo, Ana María Gómez, Barba-Ostria, Carlos, Cevallos-Robalino, Doménica, Sanches-SanMiguel, Hugo, Unigarro, Luis, Zalakeviciute, Rasa, Gadian, Naomi, López-Cortés, Andrés·2020·Diagnostic Microbiology and Infectious Disease

DOI 10.1016/j.diagmicrobio.2020.115094PMC PMC7260568

Published version of a preprint

Open this paper in CoChat — free account

Abstract

Coronaviruses are an extensive family of viruses that can cause disease in both animals and humans. The current classification of coronaviruses recognizes 39 species in 27 subgenera that belong to the family Coronaviridae. From those, at least 7 coronaviruses are known to cause respiratory infections in humans. Four of these viruses can cause common cold-like symptoms. Those that infect animals can evolve and become infectious to humans. Three recent examples of these viral jumps include SARS CoV, MERS-CoV and SARS CoV-2 virus. They are responsible for causing severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and the most recently discovered coronavirus disease during 2019 (COVID-19). COVID-19, a respiratory disease caused by the SARS-CoV-2 virus, was declared a pandemic by the World Health Organization (WHO) on 11 March 2020. The rapid spread of the disease has taken the scientific and medical community by surprise. Latest figures from 20 May 2020 show more than 5 million people had been infected with the virus, causing more than 330,000 deaths in over 210 countries worldwide. The large amount of information received daily relating to COVID-19 is so abundant and dynamic that medical staff, health authorities, academics and the media are not able to keep up with this new pandemic. In order to offer a clear insight of the extensive literature available, we have conducted a comprehensive literature review of the SARS CoV-2 Virus and the Coronavirus Diseases 2019 (COVID-19).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.diagmicrobio.2020.115094

Cites

250 of 250 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

4 retracted

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Esteves-Vieira, V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
Retracted
Epidemiological and clinical features of the 2019 novel coronavirus outbreak in ChinaPreprint
Yang, Y., Lu, Q., Liu, M., Wang, Y.-X., Zhang, A., Jalali, N., Dean, N. E., Longini, I. M., Halloran, M. E., Xu, B., et al. (2020) · medRxiv · doi:10.1101/2020.02.10.20021675 · Cited by 536
Retracted
Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients
Bae, S., Kim, M., Kim, J. Y., Cha, H.-H., Lim, J. S., Jung, J., Kim, M., Oh, D. K., Lee, M.-K., Choi, S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1342 · Cited by 193
Retracted
Notice of Retraction: Effectiveness of Surgical and Cotton Masks in Blocking SARS-CoV-2
Bae, S., Kim, M. C., Kim, J. Y., Cha, H.-H., Lim, J. S., Jung, J., Kim, M. J., Oh, D. K., Lee, M. K., Choi, S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0745 · Cited by 48
Retracted
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
La certeza de lo impredecible
Martínez–González, M. B. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,292
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
An interactive web-based dashboard to track COVID-19 in real time
Dong, E., Du, H., & Gardner, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30120-1 · Cited by 10,048
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Loop-mediated isothermal amplification of DNA
Notomi, T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.e63 · Cited by 8,805
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,745
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Chan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K. W., Bleicker, T., Brünink, S., Schneider, J. A., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,266
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., Tao, Q., Sun, Z., & Xia, L. (2020) · Radiology · doi:10.1148/radiol.2020200642 · Cited by 5,793
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,258
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,036
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,496
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 1×
“Six RBD amino acids (L455, F486, Q493, S494, N501 and Y505) are involved in the binding to ACE2 receptors [24], and five of these six residues differ between SARS-CoV and SARS-CoV-2 [25] (Figures 1a and 1b).”
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,300
Epidemiology of COVID-19 Among Children in China
Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., & Tong, S. (2020) · PEDIATRICS · doi:10.1542/peds.2020-0702 · Cited by 4,240
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
Chen, H., Guo, J., Wang, C., Luo, F., Yu, X. B., Zhang, W., Li, J., Zhao, D., Xu, D., Gong, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30360-3 · Cited by 4,029
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand
Ferguson, N. M., Laydon, D. J., Nedjati-Gilani, G. L., Imai, N., Ainslie, K. E. C., Baguelin, M., Bhatia, S., Boonyasiri, A., Cucunubá, Z. M., Cuomo-Dannenburg, G., et al. (2020) · Spiral (Imperial College London) · doi:10.25561/77482 · Cited by 3,619
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,442
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Chan, J. F., Kok, K., Zhu, Z., Chu, H., To, K. K., Yuan, S., & Yuen, K. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,127
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L. Y., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,696
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Wu, A., Peng, Y., Huang, B., Ding, X. L., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,386
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.008 · Cited by 2,367
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
Jin, Y., Cai, L., Cheng, Z., Cheng, H., Deng, T., Fan, Y., Fang, C., Huang, D., Huang, L., Huang, Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,306
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,298
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
Xu, X., Wu, X., Jiang, X., Xu, K., Ying, L.-J., Ma, C., Li, S., Wang, H., Zhang, S., Gao, H., et al. (2020) · BMJ · doi:10.1136/bmj.m606 · Cited by 2,068
A promoter-level mammalian expression atlas
The FANTOM Consortium and the RIKEN PMI and CLST (DGT) (2014) · Nature · doi:10.1038/nature13182 · Cited by 1,982
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., Zhou, M., Chen, L., Meng, S., Hu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004168117 · Cited by 1,968
Data, disease and diplomacy: GISAID's innovative contribution to global health
Elbe, S., & Buckland‐Merrett, G. (2017) · Global Challenges · doi:10.1002/gch2.1018 · Cited by 1,928
ORGANIZACION PANAMERICANA DE LA SALUD
Mujer, P., Desarrollo, S. Y., Costa, F. E., Rica, Carcedo, A. J. P., Sagot, M., de investigación, A., González, C., & Kilfoil, V. (2003) · Cited by 1,879
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831
Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis
Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., Sun, R., Wang, Y., Hu, B., Chen, W., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25727 · Cited by 1,823
A serological assay to detect SARS-CoV-2 seroconversion in humans
(2020) · doi:10.1101/2020.03.17.20037713 · Cited by 1,769
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade
Coutard, B., Valle, C., de Lamballerie, X. N., Canard, B., Seidah, N. G., & Decroly, É. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,706
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,678
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012410 · Cited by 1,625
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456
Field-deployable viral diagnostics using CRISPR-Cas13
Myhrvold, C., Freije, C. A., Gootenberg, J. S., Abudayyeh, O. O., Metsky, H. C., Durbin, A. F., Kellner, M. J., Tan, A. L., Paul, L. M., Parham, L. A., et al. (2018) · Science · doi:10.1126/science.aas8836 · Cited by 1,455
Rational use of face masks in the COVID-19 pandemic
Feng, S., Shen, C., Xia, N., Song, W., Fan, M., & Cowling, B. J. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30134-x · Cited by 1,443
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
Xu, Y., Li, X., Zhu, B., Liang, H., Fang, C., Gong, Y., Guo, Q., Sun, X., Zhao, D., Shen, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0817-4 · Cited by 1,415
Severe acute respiratory syndrome-related coronavirus : The species and its viruses – a statement of the Coronavirus Study GroupPreprint
Gorbalenya, A. E., Baker, S. C., Baric, R. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.07.937862 · Cited by 1,408
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
Return of the Coronavirus: 2019-nCoV
Gralinski, L. E., & Menachery, V. D. (2020) · Viruses · doi:10.3390/v12020135 · Cited by 1,348
Interferon-stimulated genes and their antiviral effector functions
Schoggins, J. W., & Rice, C. M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.008 · Cited by 1,342
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
Liu, C., Zhou, Q. A., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S. R., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00272 · Cited by 1,317
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know
Rasmussen, S. A., Smulian, J. C., Lednicky, J. A., Wen, T. S.-T., & Jamieson, D. J. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.02.017 · Cited by 1,306
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Song, Z., Xu, Y., Bao, L., Zhang, L., Yü, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,292
Effects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,272
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256
Performance of Radiologists in Differentiating COVID-19 from Non-COVID-19 Viral Pneumonia at Chest CT
Bai, H. X., Hsieh, B., Xiong, Z., Halsey, K., Choi, J. W., Tran, T. M. L., Pan, I., Shi, L.-B., Wang, D., Ji, M., et al. (2020) · Radiology · doi:10.1148/radiol.2020200823 · Cited by 1,254
Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study
Zhao, W., Zhong, Z., Xie, X., Yu, Q., & Liu, J. (2020) · American Journal of Roentgenology · doi:10.2214/ajr.20.22976 · Cited by 1,235
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J. M., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,174
Severe acute respiratory syndrome
Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,157
Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients
Wax, R. S., & Christian, M. D. (2020) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01591-x · Cited by 1,062
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Yu, J., Ouyang, W., Chua, M. L. K., & Xie, C. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0980 · Cited by 1,062
Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults
Xia, W., Shao, J., Guo, Y., Peng, X., Li, Z., & Hu, D. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24718 · Cited by 1,057
Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome
Wong, S. F., Chow, K. M., Leung, T. N., Ng, W. F., Ng, T. K., Shek, C. C., Ng, P. C., Lam, P. W. Y., Ho, L. C., To, W. W. K., et al. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.11.019 · Cited by 1,050
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Gao, Y., Li, T., Han, M., Li, X., Wu, D., Xu, Y., Zhu, Y., Liu, Y., Wang, X., & Wang, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25770 · Cited by 1,047
Epidemic influenza and vitamin D
Cannell, J. J., Vieth, R., Umhau, J. C., Holick, M. F., Grant, W. B., Madronich, S., Garland, C. F., & Giovannucci, E. L. (2006) · Epidemiology and Infection · doi:10.1017/s0950268806007175 · Cited by 1,039
SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum
Knoops, K., Kikkert, M., van den Worm, S. H. E., Zevenhoven-Dobbe, J. C., van der Meer, Y., Koster, A. J., Mommaas, A. M., & Snijder, E. J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060226 · Cited by 1,033
Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19
Thevarajan, I., Nguyen, T. H. O., Koutsakos, M., Druce, J. D., Caly, L., van de Sandt, C. E., Jia, X., Nicholson, S. R., Catton, M. C., Cowie, B., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0819-2 · Cited by 993
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P. R., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K., Convalescent Plasma Study Group, Nguyen‐Van‐Tam, J. S., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 985
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 920
The convalescent sera option for containing COVID-19
Casadevall, A., & Pirofski, L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 904
Commentary on Ferguson, et al., “Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand”
Eubank, S., Eckstrand, I. A., Lewis, B. L., Venkatramanan, S., MARATHE, M. V., & Barrett, C. L. (2020) · Bulletin of Mathematical Biology · doi:10.1007/s11538-020-00726-x · Cited by 882
A structural analysis of M protein in coronavirus assembly and morphology
Neuman, B. W., Kiss, G., Kunding, A. H., Bhella, D., Baksh, M. F., Connelly, S., Droese, B., Klaus, J. P., Makino, S., Sawicki, S. G., et al. (2010) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.11.021 · Cited by 870
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial*
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trialPreprint
Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., & Zhang, Z. (2020) · medRxiv · doi:10.1101/2020.03.22.20040758 · Cited by 861
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Liu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830
Care for Critically Ill Patients With COVID-19
Murthy, S., Gomersall, C. D., & Fowler, R. (2020) · JAMA · doi:10.1001/jama.2020.3633 · Cited by 782
Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis
Chu, D. K., Kim, L. H.-Y., Young, P. J., Zamiri, N., Almenawer, S. A., Jaeschke, R., Szczeklik, W., Schünemann, H. J., Neary, J. D., & Alhazzani, W. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30479-3 · Cited by 778
Pre-fusion structure of a human coronavirus spike protein
Kirchdoerfer, R. N., Cottrell, C. A., Wang, N., Pallesen, J., Yassine, H. M., Turner, H. L., Corbett, K. S., Graham, B. S., McLellan, J. S., & Ward, A. B. (2016) · Nature · doi:10.1038/nature17200 · Cited by 765
Formal guidelines: Management of acute respiratory distress syndrome.
Papazian, L., Aubron, C., Brochard, L., Chiche, J.-D., Combes, A., Dreyfuss, D., Forel, J.-M., Guérin, C., Jaber, S., Mekontso-Dessap, A., et al. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0540-9 · Cited by 761
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
Yuan, Y., Cao, D., Zhang, Y., Ma, J., Qi, J., Wang, Q., Lu, G., Wu, Y., Yan, J., Shi, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15092 · Cited by 756
Are children less susceptible to COVID-19?
Lee, P., Hu, Y.-L., Chen, P.-Y., Huang, Y., & Hsueh, P. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.02.011 · Cited by 681
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
Chen, J., Liu, D., Liu, L., Liu, P., Xu, Q., Xia, L., Ling, Y., Huang, D. F., Song, S., Zhang, D., et al. (2020) · PubMed Central · doi:10.3785/j.issn.1008-9292.2020.03.03 · Cited by 662
Immunity and immunopathology to viruses: what decides the outcome?
Rouse, B. T., & Sehrawat, S. (2010) · Nature reviews. Immunology · doi:10.1038/nri2802 · Cited by 636
mRNA vaccine delivery using lipid nanoparticles
Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R., & Blankschtein, D. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0006 · Cited by 624
Human Coronaviruses: A Review of Virus–Host Interactions
Lim, Y. X., Ng, Y. W., Tam, J. P., & Liu, D. X. (2016) · Diseases · doi:10.3390/diseases4030026 · Cited by 606
Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis
Munshi, L., Del Sorbo, L., Adhikari, N. K. J., Hodgson, C. L., Wunsch, H., Meade, M. O., Uleryk, E., Mancebo, J., Pesenti, A., Ranieri, V. M., et al. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201704-343ot · Cited by 601
RNA recognition and signal transduction by RIG‐I‐like receptors
Yoneyama, M., & Fujita, T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00727.x · Cited by 595
Coronavirus in pregnancy and delivery: rapid review
Mullins, E., Evans, D., Viner, R., O’Brien, P., & Morris, E. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.22014 · Cited by 595
Environmental Predictors of Seasonal Influenza Epidemics across Temperate and Tropical Climates
Tamerius, J. D., Shaman, J. L., Alonso, W. J., Bloom‐Feshbach, K., Uejio, C. K., Comrie, A. C., & Viboud, C. G. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003194 · Cited by 573
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Mahallawi, W. H., Khabour, O. F., Zhang, Q., Makhdoum, H., & Suliman, B. A. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.025 · Cited by 563
Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
Pang, J., Wang, M. X., Ang, I. Y. H., Tan, S. H. X., Lewis, R. F., Chen, J. I., Gutiérrez, R. A., Gwee, S. X. W., Chua, P. E. Y., Yang, Q., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030623 · Cited by 563
Influenza Seasonality: Underlying Causes and Modeling Theories
Lofgren, E., Fefferman, N. H., Naumov, Y. N., Gorski, J., & Naumova, E. N. (2006) · Journal of Virology · doi:10.1128/jvi.01680-06 · Cited by 560
Host Factors in Coronavirus Replication
de Wilde, A. H., Snijder, E. J., Kikkert, M., & van Hemert, M. J. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_25 · Cited by 554
Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China
Eastin, C. D., & Eastin, T. (2020) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2020.04.006 · Cited by 553
Roles of Humidity and Temperature in Shaping Influenza Seasonality
Lowen, A. C., & Steel, J. (2014) · Journal of Virology · doi:10.1128/jvi.03544-13 · Cited by 540
Seasonal Variation in Host Susceptibility and Cycles of Certain Infectious Diseases
Dowell, S. F. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.017301 · Cited by 534
Recent advances and perspectives of nucleic acid detection for coronavirus
Shen, M., Zhou, Y., Ye, J., AL‐maskri, A. A. A., Kang, Y., Zeng, S., & Cai, S. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.02.010 · Cited by 528
Seasonal Variation in Host Susceptibility and Cycles of Certain Infectious Diseases
Dowell, S. F. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.010301 · Cited by 525
Global Influenza Seasonality: Reconciling Patterns across Temperate and Tropical Regions
Tamerius, J. D., Nelson, M. I., Zhou, S., Viboud, C. G., Miller, M. A., & Alonso, W. J. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002383 · Cited by 519
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507
Immunopathogenesis of coronavirus infections: implications for SARS
Dandekar, A. A., & Perlman, S. M. (2005) · Nature reviews. Immunology · doi:10.1038/nri1732 · Cited by 503
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge
Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06048-11 · Cited by 477
Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020
Tong, Z., Tang, A., Li, K., Li, P., Wang, H., Yi, J.-P., Zhang, Y., & Yan, J. (2020) · Emerging infectious diseases · doi:10.3201/eid2605.200198 · Cited by 463
Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis
Silversides, J. A., Major, E., Ferguson, A. J., Mann, E. E., McAuley, D. F., Marshall, J. C., Blackwood, B., & Fan, E. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4573-3 · Cited by 458
Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Whitman, J. D., Hiatt, J. B., Mowery, C. T., Shy, B. R., Yu, R., Yamamoto, T. N., Rathore, U., Goldgof, G. M., Whitty, C., Woo, J. M., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0659-0 · Cited by 455
Is There a Role for Lung Ultrasound During the COVID ‐19 Pandemic?
Soldati, G., Smargiassi, A., Inchingolo, R., Buonsenso, D., Perrone, T., Briganti, D. F., Perlini, S., Torri, E., Mariani, A., Mossolani, E. E., et al. (2020) · Journal of Ultrasound in Medicine · doi:10.1002/jum.15284 · Cited by 454
Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity
Cheng, K. K., Lam, T. H., & Leung, C. C. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30918-1 · Cited by 454
Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus Macaques
Liu, L., Wei, Q., Alvarez, X. A., Wang, H., Du, Y., Zhu, H., Jiang, H., Zhou, J., Lam, P., Zhang, L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02292-10 · Cited by 453
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
Ng, O.-W., Chia, A., Tan, A. T., Jadi, R. S., Leong, H. N., Bertoletti, A., & Tan, Y.-J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.063 · Cited by 436
Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China
Shanghai (2020) · Cited by 433
RIG-I in RNA virus recognition
Kell, A. M., & Gale, M. (2015) · Virology · doi:10.1016/j.virol.2015.02.017 · Cited by 424
Stability of SARS Coronavirus in Human Specimens and Environment and Its Sensitivity to Heating and UV Irradiation
Shu-Mingduan, Xin-Shengzhao, Rui-Fuwen, Jing-Jinghuang, Guo-Huapi, Su-XIANGZHANG, Junhan, Bi, S., Liruan, Xiao-Pingdong, et al. (2003) · 生物医学与环境科学：英文版 · Cited by 419
Clinical trials on drug repositioning for COVID-19 treatment
Viveiros-Rosa, S. G., & Santos, W. C. (2020) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2020.40 · Cited by 419
Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2
Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., Xu, Y., et al. (2020) · doi:10.1101/2020.03.13.990226 · Cited by 419
Novel corona virus disease (COVID‐19) in pregnancy: What clinical recommendations to follow?
Liang, H., & Acharya, G. (2020) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13836 · Cited by 417
COVID-19 in patients with HIV: clinical case series
Blanco, J. L., Ambrosioni, J., García, F., Martínez, E., Soriano, À., Mallolas, J., & Miró, J. M. (2020) · The Lancet HIV · doi:10.1016/s2352-3018(20)30111-9 · Cited by 417
Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Park, G.-S., Ku, K. B., Baek, S., Kim, S., Kim, S. I., Kim, B., & Maeng, J. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.03.006 · Cited by 406
Staff safety during emergency airway management for COVID-19 in Hong Kong
Cheung, J. C.-H., Ho, L. T., Cheng, J. V., Cham, E., & Lam, K. N. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30084-9 · Cited by 399
An Explanation for the Seasonality of Acute Upper Respiratory Tract Viral Infections
Eccles, R. (2002) · Acta Oto-Laryngologica · doi:10.1080/00016480252814207 · Cited by 396
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature
Alfaraj, S. H., Al‐Tawfiq, J. A., & Memish, Z. A. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.04.005 · Cited by 388
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Li, Y., Xie, Z., Lin, W., Cai, W., Wen, C., Guan, Y., Mo, X., Wang, J., Wang, Y., Peng, P., et al. (2020) · Med · doi:10.1016/j.medj.2020.04.001 · Cited by 385
Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation.
Duan, S., Zhao, X.-S., Wen, R.-F., Huang, J.-J., Guohua, P., Su-xiang, Z., Han, J., Bi, S., Ruan, L., & Dong, X. (2003) · PubMed · Cited by 383
Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study GroupPreprint
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.1101/2020.02.07.937862v1 · Cited by 382
Management of Critically Ill Adults With COVID-19
Poston, J. T., Patel, B. K., & Davis, A. M. (2020) · JAMA · doi:10.1001/jama.2020.4914 · Cited by 373
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer
Chávez‐MacGregor, M., Clarke, C. A., Lichtensztajn, D. Y., & Giordano, S. H. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3856 · Cited by 372
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
Corman, V. M., Müller, M. A., Costabel, U., Timm, J., Binger, T., Meyer, B., Kreher, P., Lattwein, E., Eschbach-Bludau, M., Nitsche, A., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.49.20334-en · Cited by 360
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial
Lamontagne, F., Richards-Belle, A., Thomas, K., Harrison, D. A., Sadique, M. Z., Grieve, R. D., Camsooksai, J., Darnell, R., Gordon, A. C., Henry, D., et al. (2020) · JAMA · doi:10.1001/jama.2020.0930 · Cited by 354
Treatment for severe acute respiratory distress syndrome from COVID-19
Matthay, M. A., Aldrich, J. M., & Gotts, J. E. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30127-2 · Cited by 351
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection
Saleh, M. A., Gabriels, J. K., Chang, D., Kim, B. S., Mansoor, A., Mahmood, E., Makker, P., Ismail, H., Goldner, B. G., Willner, J., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008662 · Cited by 340
Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine
Tebas, P., Roberts, C. C., Muthumani, K., Reuschel, E. L., Kudchodkar, S. B., Zaidi, F. I., White, S., Khan, A. S., Racine, T., Choi, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708120 · Cited by 337
Exhaled air dispersion during high-flow nasal cannula therapyversusCPAPviadifferent masks
Hui, D. S. C., Chow, B., Lo, T., Tsang, O. T. Y., Ko, F. W. S., Ng, S. S., Gin, T., & Chan, M. T. V. (2019) · European Respiratory Journal · doi:10.1183/13993003.02339-2018 · Cited by 333
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019
Zeng, Q., Yu, Z., Gou, J.-J., Li, G., Ma, S.-H., Zhang, G.-F., Xu, J., Lin, W., Cui, G.-L., Zhang, M.-M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa228 · Cited by 330
[Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province].
Zhang, L., Jiang, Y., Wei, M., Cheng, B. H., Zhou, X. C., Li, J., Tian, J. H., Dong, L., & Hu, R. H. (2020) · PubMed · doi:10.3760/cma.j.cn112141-20200218-00111 · Cited by 324
Evaluation of nine commercial SARS-CoV-2 immunoassaysPreprint
Lassaunière, R., Frische, A., Harboe, Z. B., Nielsen, A. C. Y., Fomsgaard, A., Krogfelt, K. A., & Jørgensen, C. S. (2020) · medRxiv · doi:10.1101/2020.04.09.20056325 · Cited by 319
Colloids versus crystalloids for fluid resuscitation in critically ill people
Lewis, S. R., Pritchard, M. W., Evans, D. J., Butler, A. R., Alderson, P., Smith, A. F., & Roberts, I. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000567.pub7 · Cited by 315
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway
Jaume, M., Yip, M., Cheung, C. Y., Leung, N., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R. M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00671-11 · Cited by 312
Profile of Specific Antibodies to the SARS-Associated Coronavirus
Li, G., Chen, X., & Xu, A. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307313490520 · Cited by 307
Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response
Kindler, E., Thiel, V., & Weber, F. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.006 · Cited by 296
Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells
Yoshikawa, T., Hill, T. E., Li, K., Peters, C. J., & Tseng, C.-T. K. (2008) · Journal of Virology · doi:10.1128/jvi.01792-08 · Cited by 291
Two‐Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome
Liu, W. Y., Fontanet, A. L., Zhang, P., Zhan, L., Xin, Z., Baril, L., Tang, F., Lv, H., & Cao, W. (2006) · The Journal of Infectious Diseases · doi:10.1086/500469 · Cited by 287
Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis
Kontou, P. I., Braliou, G. G., Dimou, N. L., Nikolopoulos, G. K., & Bagos, P. G. (2020) · Diagnostics · doi:10.3390/diagnostics10050319 · Cited by 287
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel
Adams, E. R., Ainsworth, M. A., Anand, R., Andersson, M. I., Auckland, K., Baillie, J. K., Barnes, E. J., Beer, S., Bell, J. I., Berry, T., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15927.1 · Cited by 283
Untitled work
(2020) · doi:10.1101/2020.04.15.20066407 · Cited by 278
Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV
Baruah, V., & Bose, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25698 · Cited by 273
Guidelines for pregnant women with suspected SARS-CoV-2 infection
Favre, G., Pomar, L., Qi, X., Nielsen‐Saines, K., Musso, D., & Baud, D. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30157-2 · Cited by 258
1 ,25-dihydroxyvitamin D3 is a potent suppressor of interferon -mediated macrophage activation
Helming, L. (2005) · Blood · doi:10.1182/blood-2005-03-1029 · Cited by 252
Test performance evaluation of SARS-CoV-2 serological assaysPreprint
Whitman, J. D., Hiatt, J. B., Mowery, C. T., et al. (2020) · medRxiv · doi:10.1101/2020.04.25.20074856 · Cited by 252
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
Yang, Z., Werner, H. C., Kong, W., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 250
Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus
Yip, M., Leung, N., Cheung, C. Y., Li, P. H., Lee, H. H. Y., Daëron, M., Peiris, M. J. S., Bruzzone, R., & Jaume, M. (2014) · Virology Journal · doi:10.1186/1743-422x-11-82 · Cited by 249
Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
Gu, H., Xie, Z., Li, T., Zhang, S., Lai, C., Zhu, P., Wang, K., Han, L., Duan, Y., Zhao, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep19840 · Cited by 247
ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals
Poon, L. C., Yang, H., Lee, J. C. S., Copel, J. A., Leung, T. Y., Zhang, Y., Chen, D., & Prefumo, F. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.22013 · Cited by 242
Vasopressors for hypotensive shock
Gamper, G., Havel, C., Arrich, J., Losert, H., Pace, N. L., Müllner, M., & Herkner, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003709.pub4 · Cited by 239
Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections
Nelemans, T., & Kikkert, M. (2019) · Viruses · doi:10.3390/v11100961 · Cited by 228
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Yong, C. Y., Ong, H. K., Yeap, S. K., Ho, K. L., & Tan, W. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01781 · Cited by 224
Global Patterns in Seasonal Activity of Influenza A/H3N2, A/H1N1, and B from 1997 to 2005: Viral Coexistence and Latitudinal Gradients
Finkelman, B. S., Viboud, C. G., Koelle, K., Ferrari, M. J., Bharti, N., & Grenfell, B. T. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001296 · Cited by 222
The role of ultrasound lung artifacts in the diagnosis of respiratory diseases
Soldati, G., Demi, M., Smargiassi, A., Inchingolo, R., & Demi, L. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1565997 · Cited by 206
Novel coronavirus infection and pregnancy
Yang, H., Wang, C., & Poon, L. C. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.22006 · Cited by 198
Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, ChinaPreprint
Wang, Y., Jiang, W., He, Q., Wang, C., Liu, B., Zhou, P., Dong, N., & Tong, Q. (2020) · medRxiv · doi:10.1101/2020.03.06.20032342 · Cited by 190
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
Du, L., Zhao, G., He, Y., Guo, Y., Zheng, B., Jiang, S., & Zhou, Y. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.031 · Cited by 180
Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador
Ortiz‐Prado, E., Simbaña‐Rivera, K., Diaz, A. M., Barreto, A., Moyano, C., Arcos, V., Vásconez-González, E., Vásconez-González, J., Simbaña-Guaycha, F., Molestina-Luzuriaga, M., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008958 · Cited by 158
Self-citation
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
Ford, N. P., Vitória, M., Rangaraj, A., Norris, S. L., Calmy, A., & Doherty, M. C. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25489 · Cited by 157
Live cell imaging of single RNA molecules with fluorogenic Mango II arrays
Cawte, A. D., Unrau, P. J., & Rueda, D. (2020) · Nature Communications · doi:10.1038/s41467-020-14932-7 · Cited by 152
Clinical diagnosis of 8274 samples with 2019-novel coronavirus in WuhanPreprint
Wang, M., Wu, Q., Xu, W., Qiao, B., Wang, J., Zheng, H., Jiang, S., Mei, J., Wu, Z., Deng, Y., et al. (2020) · medRxiv · doi:10.1101/2020.02.12.20022327 · Cited by 150
Influenza Epidemics in the United States, France, and Australia, 1972–19971
Viboud, C. G., Boëlle, P., Pakdaman, K., Carrat, F., Valleron, A., & Flahault, A. (2004) · Emerging infectious diseases · doi:10.3201/eid1001.020705 · Cited by 146
Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020
Bordi, L., Nicastri, E., Scorzolini, L., Di, A., Capobianchi, M. R., Castilletti, C., & Lalle, E. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.8.2000170 · Cited by 145
An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)Preprint
Li, Y., Xie, Z., Lin, W., et al. (2020) · medRxiv · doi:10.1101/2020.03.19.20038984 · Cited by 143

Research works printed but not linked: 19

Abbott, 2020, Abbott launches Novel Coronavirus Test, Abbott
Bao, 2020, Reinfection could not occur in SARS-CoV-2 infected rhesus macaques, bioRxiv
Cao, 2020, A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19, N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282 · DOI
Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 Novel Coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 · DOI · Paper page
2020, Chinese Clinical Trial Registry
Cohen, 2020, KupferschmidtFeb. 11 K, 2020, Pm 5:15. Labs scramble to spot hidden coronavirus infections, Science | AAAS
Corman, 2020, Detection of 2019 Novel Coronavirus (2019-nCoV) by real-time RT-PCR, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, 25, 1
Coronavirus Update, 2020, Hologic molecular test receives FDA Emergency Use Authorization, Hologic
Duan, 2020, Effectiveness of convalescent plasma therapy in severe COVID-19 patients, Proc Natl Acad Sci, 117, 9490, 10.1073/pnas.2004168117 · DOI
Feng, 2020, Rational use of face masks in the COVID-19 pandemic, Lancet Respir Med, 8, 434, 10.1016/S2213-2600(20)30134-X · DOI
Guan, 2020, Clinical characteristics of Coronavirus Disease 2019 in China, N Engl J Med, 19, 1
Hoffmann, 2020, SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor article SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 1, 10.1016/j.cell.2020.02.052 · DOI · Paper page
Hopkins, 2020, Drugmaker Takeda is working on coronavirus drug, Wall Street J
Huang, 2020, Clinical features of patients infected with 2019 Novel Coronavirus in Wuhan, China The Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
Medical Association A, 2019, COVID-19, JAMA, 2019
Remuzzi A, Remuzzi G. Imported from https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30627-9/fulltext?utm_campaign=tlcoronavirus20&utm_source=twitter&utm_medium=social. Lancet. 2020;2:10–3.
Shen, 2015, cr ip t ce pt e d us cr ip t Ac ce pt us, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, 26, 1
Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China, JAMA - J Am Med Assoc, 1
Zeng, 2020, Effect of convalescent plasma therapy on viral shedding and survival in COVID-19 patients, J Infect Dis, jiaa228

Sorted by citations

COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Kyriakidis, N. C., López‐Cortés, A., Vásconez-González, J., Barreto-Grimaldos, A., & Ortiz‐Prado, E. (2021) · npj Vaccines · doi:10.1038/s41541-021-00292-w · Cited by 700
Self-citation
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Tali, S. H. S., LeBlanc, J. J., Sadiq, Z., Oyewunmi, O. D., Camargo, C., Nikpour, B., Armanfard, N., Sagan, S. M., & Jahanshahi‐Anbuhi, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00228-20 · Cited by 430
Plastics in the time of COVID-19 pandemic: Protector or polluter?
Parashar, N., & Hait, S. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.144274 · Cited by 376

See all 463

Authors: Ortiz-Prado, E., Simbaña-Rivera, K., Gómez- Barreno, L., Rubio-Neira, M., Guaman, L. P., Kyriakidis, N. C., Muslin, C., Jaramillo, A. M. G., Barba-Ostria, C., Cevallos-Robalino, D., Sanches-SanMiguel, H., Unigarro, L., Zalakeviciute, R., Gadian, N., & López-Cortés, A.
Affiliations: Pediatric Hospital "Baca Ortiz" (EC)
Universidad de Las Américas (EC)
Hospital General del Sur de Quito, IESS (EC)
SOLCA Núcleo de Quito (EC)
University of Southampton (GB)
ORCID: Kyriakidis, Nikolaos C
Muslin, Claire
Cevallos-Robalino, Doménica
Unigarro, Luis
Venue: Diagnostic Microbiology and Infectious Disease
Publisher: Elsevier BV
Published: 2020-09
Volume: 98
Issue: 1
Pages: 115094
ISSN: 0732-8893 (ISSN-L)
DOI: 10.1016/j.diagmicrobio.2020.115094
PMC: PMC7260568
OpenAlex: W3017016822
Cited by: 458
References: 275
Citations by year: 2026: 7 · 2025: 19 · 2024: 36 · 2023: 72 · 2022: 108 · 2021: 151 · 2020: 65
FWCI: 4.68
Type: journal article
Language: en
Open access: green
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Diagnostic Microbiology and Infectious Disease (publishedVersion)
Preprints.org (acceptedVersion, cc-by)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
Keywords: SARS-CoV-2, COVID-19 pandemic, coronavirus, Coronaviridae, SARS, MERS, zoonotic transmission, respiratory infections, pandemic, clinical characterization, molecular characterization
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Humans, Pneumonia, Viral, Virus Replication, HIV Infections, Genome, Viral, Coronavirus Infections, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks